Another 65-year-old woman with SLE, APS (triple aPL positivity), and DLBCL achieved ongoing complete remission of DLBCL after anti-CD19 CAR T-cell treatment, along with seroconversion of lupus anticoagulant, anti-cardiolipin, and anti-beta2 glycoprotein I antibodies (114). This evidence concerns the gene CD19 and systemic lupus erythematosus.